Comparative Efficacy of Corticosteroid Injection, Extracorporeal Shock Wave Therapy, and Radiofrequency Ablation for Chronic Plantar Fasciitis: a Prospective Randomized Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Plantar Fasciitis
- Sponsor
- Kars Harakani State Hospital
- Enrollment
- 49
- Locations
- 1
- Primary Endpoint
- Visual Analog Scale (VAS) scores
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
Chronic plantar fasciitis is a prevalent condition causing persistent heel pain, often refractory to conservative treatments. This prospective randomized controlled trial aimed to compare the effectiveness of corticosteroid injection (CSI) , extracorporeal shock wave therapy (ESWT), and radiofrequency thermal lesioning (RTL) in the management of chronic plantar fasciitis.
Detailed Description
Based on the investigators' understanding of the literature there are no randomized, controlled, prospective studies comparing the therapeutic effects of CSI, ESWT and RTL for recalcitrant plantar fasciitis. In this study, the investigators investigated and compared the outcomes of three treatment techniques in participants who had exhausted conservative treatment options over the past six months.
Investigators
Erdem Sahin
Medical Doctor
Kars Harakani State Hospital
Eligibility Criteria
Inclusion Criteria
- •Persistant heel pain for ≥ 6 months
- •No response to at least 6 weeks of conservative treatment (including at least two of the following: NSAIDs, stretching exercises, ice, heel pads, physical therapy, or night splints)
- •VAS ≥ 5 following the first step in the morning or after periods of prolonged inactivity
- •Willingness to participate in the study
Exclusion Criteria
- •Previous foot or ankle surgery, major trauma
- •Tumor, osteomyelitis, or complex regional pain syndrome in the affected limb
- •Allergy to local anesthesia or NSAIDs
- •Pregnancy or breastfeeding
- •History of calcaneal fracture
- •Previous cortisone injection, ESWT, or RTL for similar complaints
- •Age \< 18
- •Use of medications for neuropathic pain (Pregabalin, Gabapentin)
- •Proximal nerve lesion (e.g., spinal stenosis, sciatica, tarsal tunnel syndrome)
- •Regional skin or subcutaneous infections, fat pad atrophy
Outcomes
Primary Outcomes
Visual Analog Scale (VAS) scores
Time Frame: 1st month. 3rd month, 6th month
Pain score (1 to 10 points)
Foot Function Index (FFI)
Time Frame: 1st month. 3rd month, 6th month,
Function score (The FFI is a self-administered index consisting of 23 items divided into 3 sub-scales.)
Roles and Maudsley Score
Time Frame: 1st month. 3rd month, 6th month,
The Roles and Maudsley score is an established subjective 4-point patient assessment of pain and limitations of activity (1 = excellent result with no symptoms following treatment; 2 = significant improvement from pretreatment; 3 = patient somewhat improved; 4 = poor, symptoms identical or worse than pretreatment)